Marta Chesi, PhD

  • 8862 Citations
  • 38 Scopus h-Index
19962020
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Marta Chesi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Multiple Myeloma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Receptor, Fibroblast Growth Factor, Type 3 Medicine & Life Sciences
Tumors Chemical Compounds
Monoclonal Gammopathy of Undetermined Significance Medicine & Life Sciences
Plasma Cells Medicine & Life Sciences
Polyploidy Medicine & Life Sciences
Disease Progression Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2014 2020

Multiple Myeloma
Oncolytic Virotherapy
Clonal Evolution
Vesicular Stomatitis
Research
Multiple Myeloma
Immunotherapy
Standard of Care
Phase II Clinical Trials
Pharmaceutical Preparations

Research Output 1996 2019

6 Citations (Scopus)

Bone marrow transplantation generates T cell-dependent control of myeloma in mice

Vuckovic, S., Minnie, S. A., Smith, D., Gartlan, K. H., Watkins, T. S., Markey, K. A., Mukhopadhyay, P., Guillerey, C., Kuns, R. D., Locke, K. R., Pritchard, A. L., Johansson, P. A., Varelias, A., Zhang, P., Huntington, N. D., Waddell, N., Chesi, M., Miles, J. J., Smyth, M. J. & Hill, G. R., Jan 2 2019, In : Journal of Clinical Investigation. 129, 1, CI98888.

Research output: Contribution to journalArticle

Bone Marrow Transplantation
T-Lymphocytes
Autologous Transplantation
Tissue Donors
Multiple Myeloma

Chemotherapy followed by anti-CD137 mAb immunotherapy improves disease control in a mouse myeloma model

Guillerey, C., Nakamura, K., Pichler, A. C., Barkauskas, D., Krumeich, S., Stannard, K., Miles, K., Harjunpää, H., Yu, Y., Casey, M., Doban, A. I., Lazar, M., Hartel, G., Smith, D., Vuckovic, S., Teng, M. W. L., Bergsagel, P. L., Chesi, M., Hill, G. R., Martinet, L. & 1 others, Smyth, M. J., Jul 25 2019, In : JCI Insight. 4, 14, :e125932.

Research output: Contribution to journalArticle

Open Access
Multiple Myeloma
Immunotherapy
Drug Therapy
T-Lymphocytes
Therapeutics
1 Citation (Scopus)

Dynamic CD138 surface expression regulates switch between myeloma growth and dissemination

Akhmetzyanova, I., McCarron, M. J., Parekh, S., Chesi, M., Bergsagel, P. L. & Fooksman, D. R., Jan 1 2019, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalArticle

Growth
Syndecan-1
Bone and Bones
Plasma Cells
Cell Movement

MYC dysregulation in the progression of multiple myeloma

MMRF CoMMpass Network, Jan 1 2019, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalLetter

Multiple Myeloma

Oncolytic immunotherapy and bortezomib synergy improves survival of refractory multiple myeloma in a preclinical model

Thirukkumaran, C. M., Shi, Z. Q., Nuovo, G. J., Luider, J., Kopciuk, K. A., Dong, Y., Mostafa, A. A., Thakur, S., Gratton, K., Yang, A., Chin, A. C., Coffey, M. C., Jimenez-Zepeda, V. H., Stewart, D., Chesi, M., Bergsagel, P. L. & Morris, D., Mar 12 2019, In : Blood advances. 3, 5, p. 797-812 16 p.

Research output: Contribution to journalArticle

Open Access
Multiple Myeloma
Immunotherapy
Survival
Neoplasms
Therapeutics